Scilex Holding Co (SCLX)
Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles. Beyond this, the company's development pipeline includes SP-102, a viscous gel corticosteroid for epidural administration, currently undergoing Phase III trials for lumbosacral radicular pain. Another candidate, SP-103, is progressing through Phase II trials for managing low back pain. Furthermore, SP-104, a novel, low-dose, delayed-release naltrexone hydrochloride formulation, has successfully concluded Phase I clinical testing for the treatment of fibromyalgia. Its corporate offices are situated in Palo Alto, California. Scilex Holding Company operates as a subsidiary of Sorrento Therapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Drug Manufacturers - General
Scilex Holding Company
NASDAQ:SCLXHealthcare · Drug Manufacturers - General
-10.19%$1.85
AH$1.89+2.16%vs close
Mkt Cap$15.71M
Float7.46M
O/S8.49M
Vol
$ Vol
RVOL
Inst Own8.3%
SI2.0%
Earnings
Dilution
Financials Summary
Revenue$30.25M
Net Income-$358.73M
Total Assets$364.98M
Free Cash Flow$3.68M
Debt & Equity
Total Debt$132.54M
Total Equity-$207.78M
Preferred Stock$1K
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
2-year cumulative
1:35
Nasdaq bars a compliance period at 1:250
- 1:35Reverse splitApr 15, 202535 shares → 1
- 1:10Reverse splitMay 7, 201010 shares → 1
Balance Sheet Details
Assets$364.98M
Liabilities$576.73M
Accounts Receivable$15.24M
Accounts Payable$86.27M
Inventory$4.79M
PP&E (Net)$28.42M
Goodwill$13.48M
Intangible Assets$59.09M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $30.25M | $56.59M | $46.74M | $38.03M | $31.32M | $23.56M | $21.03M |
| YoY Growth | -46.5% | 21.1% | 22.9% | 21.4% | 32.9% | 12.0% | - |
| Cost of Revenue | $15.22M | $16.69M | $15.68M | $10.8M | $3.63M | $2.15M | $5.8M |
| Gross Profit | $15.03M | $39.9M | $31.06M | $27.24M | $27.68M | $21.41M | $15.23M |
| Gross Margin | 49.7% | 70.5% | 66.5% | 71.6% | 88.4% | 90.9% | 72.4% |
| Research and Development | $20.71M | $9.64M | $12.75M | $9.05M | $9.2M | $9.96M | $85.52M |
| Selling, General, and Administrative | $266.63M | $119.02M | $119.64M | $64.89M | $50.58M | $42.97M | $64.7M |
| Other | $0 | -$5.36M | $4.11M | $3.92M | $3.74M | $3.74M | $3.71M |
| Total Operating Expenses | $287.33M | $123.3M | $136.49M | $77.87M | $63.52M | $56.67M | $153.93M |
| Operating Income (EBIT) | -$272.3M | -$83.4M | -$105.43M | -$50.63M | -$35.84M | -$35.26M | -$138.69M |
| Operating Margin | -900.1% | -147.4% | -225.6% | -133.1% | -114.4% | -149.7% | -659.4% |
| Interest Expense | $11.46M | $1.96M | $1.07M | $9.6M | $11.76M | $13.12M | $16.89M |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $460K |
| Other Income (Expense) | -$101.72M | $10.59M | -$8.89M | $27.27M | -$52.58M | -$12.31M | -$39.9M |
| Income Before Tax (EBT) | -$374.03M | -$72.81M | -$114.32M | -$23.36M | -$88.42M | -$47.57M | -$178.59M |
| Income Tax Expense | $26K | -$1K | $13K | $4K | $5K | -$53K | $2K |
| Net Income | -$358.73M | -$72.81M | -$114.33M | -$23.36M | -$88.42M | -$47.52M | -$178.59M |
| Net Income Margin | -1185.8% | -128.7% | -244.6% | -61.4% | -282.4% | -201.7% | -849.1% |
| Supplementary Data | |||||||
| EPS | -36.48 | -19.43 | -44.85 | -6.09 | -23.29 | -0.01 | -1.27 |
| Diluted EPS | -36.48 | -19.43 | -44.85 | -6.09 | -23.29 | -0.01 | -1.27 |
| Weighted Average OS | 11.03M | 6.95M | 3.72M | 3.83M | 3.80M | 4.03M | 4.03M |
| EBITDA | -$357.94M | -$66.8M | -$109.1M | -$9.79M | -$72.88M | -$31.48M | -$157.95M |
| EBITDA Margin | -1183.2% | -118.0% | -233.4% | -25.8% | -232.7% | -133.6% | -751.0% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Assets | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | $4.96M | $3.27M | $3.92M | $2.18M | $4.34M | $4.84M |
| Short-Term Investments | $6.03M | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $10.98M | $3.27M | $3.92M | $2.18M | $4.34M | $4.84M |
| Accounts Receivable | $15.24M | $26.44M | $34.6M | $21.24M | $14.27M | $13.13M |
| Inventory | $4.79M | $2.44M | $4.21M | $1.38M | $2.56M | $1.15M |
| Other Current Assets | $7.34M | $9.4M | $0 | $0 | $1.83M | $0 |
| Total Current Assets | $38.36M | $41.55M | $46.78M | $29.61M | $23M | $22.42M |
| Long-Term Assets | ||||||
| Property, Plant & Equipment Net | $28.42M | $2.93M | $3.67M | $1.9M | $2.11M | $2.52M |
| Goodwill | $13.48M | $13.48M | $13.48M | $13.48M | $13.48M | $13.48M |
| Intangible Assets | $59.09M | $32.45M | $36.48M | $40.59M | $38.8M | $42.54M |
| Long-Term Investments | $1M | $2.42M | $808K | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $224.64M | $119K | $89K | $944K | $538K | $538K |
| Total Long-Term Assets | $326.62M | $51.41M | $54.53M | $56.92M | $54.93M | $59.08M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $364.98M | $92.95M | $101.31M | $86.53M | $77.93M | $81.5M |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payable | $86.27M | $52.62M | $40.95M | $8.45M | $4.28M | $8.12M |
| Short-Term Debt | $92.28M | $34.88M | $108.43M | $0 | $57.56M | $28.9M |
| Current Income Tax Payable | $0 | $876K | $1.45M | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $301.79M | $169.04M | $491K | $264K | $0 | $26.66M |
| Total Current Liabilities | $483.65M | $259.63M | $250.38M | $44.84M | $169.42M | $78.48M |
| Long-Term Liabilities | ||||||
| Long-Term Debt | $27.12M | $845K | $17.04M | $0 | $95.54M | $107.66M |
| Long-Term Unearned Revenue | $0 | $2.69M | $0 | $0 | $5.19M | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $52.81M | $20.91M | $4.59M | $4.78M | $30.51M | $35.4M |
| Total Long-Term Liabilities | $93.08M | $25.96M | $23.87M | $5.45M | $132.39M | $144.71M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $576.73M | $285.59M | $274.25M | $50.29M | $301.81M | $223.19M |
| Stockholders' Equity | ||||||
| Preferred Stock | $1K | $1K | $0 | $3K | $0 | $0 |
| Common Stock | $1K | $24K | $16K | $14K | $13K | $20K |
| Retained Earnings | -$921.79M | -$563.05M | -$490.25M | -$375.91M | -$352.55M | -$264.13M |
| Comprehensive Income & Other | -$5.8M | $6.32M | $0 | -$0 | $0 | $0 |
| Other Stockholders' Equity | $714M | $370.39M | $317.29M | $412.14M | $128.66M | $122.42M |
| Total Equity | -$207.78M | -$192.64M | -$172.94M | $36.24M | -$223.88M | -$141.68M |
| Minority Interest | -$3.97M | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $368.95M | $92.95M | $101.31M | $86.53M | $77.93M | $81.5M |
| Supplementary Data | ||||||
| Total Debt | $132.54M | $37.96M | $128.46M | $1.41M | $154.75M | $138.63M |
| Net Debt | $127.59M | $34.69M | $124.54M | -$774K | $150.41M | $133.79M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$358.73M | -$72.81M | -$114.33M | -$23.36M | -$88.42M | -$47.52M | -$178.59M |
| Depreciation & Amortization | $4.62M | $4.05M | $4.15M | $3.96M | $3.78M | $3.78M | $3.75M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $12.76M | -$800K | $23.3M |
| Stock-Based Compensation | $15.49M | $15.69M | $14.6M | $5.28M | $5.82M | $5.39M | $4.33M |
| Changes in Working Capital: | |||||||
| Accounts Receivable | $13.84M | -$6.27M | -$13.36M | -$6.97M | -$1.14M | -$598K | -$12.36M |
| Inventory | $1.8M | $1.46M | -$2.84M | $1.18M | -$1.42M | $2.38M | -$1.12M |
| Accounts Payable | $13.12M | $7.42M | $19.88M | $2.81M | -$3.84M | -$4.06M | $4.27M |
| Other Working Capital | $85.21M | $62.23M | $62.12M | $48.65M | $20M | $9.34M | $5.13M |
| Total Working Capital Change | $113.97M | $64.84M | $65.8M | $45.67M | $13.6M | $7.06M | -$4.07M |
| Other Non-Cash Items | $228.47M | $7.58M | $9.08M | -$52.8M | $23.79M | $623K | $90.86M |
| Net Cash from Operating | $3.82M | $19.35M | -$20.71M | -$21.26M | -$28.66M | -$31.46M | -$60.42M |
| Investing Activities | |||||||
| Capital Expenditures | -$133K | -$600K | -$30K | -$2.07M | $0 | -$25K | -$584K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | -$17.04M |
| Purchases of Investments | $0 | -$2.08M | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $4.22M | $0 | -$300K | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $4.08M | -$2.67M | -$330K | -$2.07M | $0 | -$25K | -$17.62M |
| Financing Activities | |||||||
| Debt Repaid | - | $64.21M | $23.27M | $31.25M | $19.69M | $37.62M | - |
| Common Stock Issuance | $27.88M | $44.64M | $35.46M | $96K | $0 | -$93K | $0 |
| Common Stock Repurchases | $0 | $0 | -$10M | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$30.53M | $1.44M | -$2.6M | $52.33M | $47.85M | $18.54M | $15.78M |
| Net Cash from Financing | -$5.46M | -$18.13M | $23.58M | $21.17M | $28.16M | -$19.17M | $15.78M |
| Forex Effect | -$756K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $1.68M | -$1.46M | $2.54M | -$2.15M | -$501K | -$50.66M | -$62.27M |
| Supplementary Data | |||||||
| Operating Cash Flow | $3.82M | $19.35M | -$20.71M | -$21.26M | -$28.66M | -$31.46M | -$60.42M |
| Capital Expenditure | -$133K | -$600K | -$330K | -$2.07M | $0 | -$25K | -$584K |
| Free Cash Flow | $3.68M | $18.75M | -$21.04M | -$23.32M | -$28.66M | -$31.49M | -$61.01M |
| Cash at Beginning | $3.27M | $4.73M | $2.18M | $4.34M | $4.84M | $55.49M | $117.76M |
| Cash at End | $4.96M | $3.27M | $4.73M | $2.18M | $4.34M | $4.84M | $55.49M |